Print
Health Care

Alcami Buys Massachusetts Company

By Staff Reports, posted Dec 16, 2021
Alcami Corp. announced that it has acquired another company that serves the pharmaceutical industry. (File photo)

Alcami Corp., a Wilmington-based company, announced this week it has acquired another pharma firm.

Itself a pharmaceutical and biotech contract development and manufacturing organization (CDMO), Alcami bought Masy Systems Inc., a provider of cGMP Biostorage and pharma support services, for an undisclosed amount, according to a news release. 

The abbreviation "cGMP" in the pharmaceutical industry stands for "current good manufacturing practices."

"The acquisition of Masy adds complementary service offerings and further reinforces Alcami's ambitious growth and expansion initiatives," said Patrick Walsh, chairman and CEO of Alcami, in the release.

Alcami company officials announced in January that it was investing $2 million in its Wilmington site, 2320 Scientific Park Drive, to expand its oral solid development and manufacturing capabilities. The firm has about 400 employees in Wilmington.

Masy was founded in 1984 by entrepreneurs Laurie and John Masiello and operates three cGMP Biostorage facilities in Massachusetts, all within an hour of Boston and Cambridge, with a fourth facility set to open in early 2022, the release stated.

"The company offers secure and tightly controlled cGMP temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds and medical devices," according to the release.

The company's pharma support services include equipment calibration, large-scale validation and qualification projects, SenseAnywhere monitoring solutions and validation and calibration equipment sales and rentals, the release stated.

Masy's additional pharma support service operations are located in California, Pennsylvania, New Jersey and North Carolina.

"We built an amazing company at Masy and are thrilled to partner with the Alcami team, as our combined resources and capabilities will result in enhanced support for our customers," Lauri Masiello stated in the release.

Benefits for Masy clients include immediate access to Alcami's service offerings ranging from analytical development and testing to full drug product development and manufacturing, both sterile fill-finish and oral solid dose, according to the release.

The release also said, "Similarly, Alcami's extensive client base will have access to Masy's available and growing cGMP Biostorage capacity and extensive pharma support services."

Ico insights

INSIGHTS

SPONSORS' CONTENT
Tommytaylor ceo unitedway

I Got 99 Problems But a 501(c)(3) Ain’t One

Tommy Taylor - United Way
Jc300 dsc 2735

For Great Board Members Who Don’t Want to Ask for Money

JC Lyle - Wilmington Area Rebuilding Ministry
Jessiepowellheadshot webversion

5 Reasons to Build Custom Franchise Software

Jessie Powell - Wide Open Tech

Trending News

Wilmington-based Firm Buys Carolina Beach Motel For $5M

Cece Nunn - Jun 24, 2022

Fit4Life Health Clubs To Open Two Gyms As Upgrades Continue

Johanna Cano - Jun 24, 2022

In The Current Issue

Info Junkie: Hunter Ingram

Hunter Ingram, assistant museum director of the Burgwin-Wright House and Gardens, shares his top info and tech picks....


'Sauce Boss' Built Business From Scratch

It was the summer of 1989, and Sean O’Rourke had concocted his first iteration of what would eventually become the Surfer Slappin! barbecue...


Cruises Can Spark Return Trips

While Charleston and many Florida cities are well-known for being popular ports of call for cruise lines, few people realize that Wilmington...

Book On Business

The 2022 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Trying to Grow a Business?
2020 Health Care Heroes
2020 WilmingtonBiz 100